Author/Authors :
Kothadia, Jiten P. MUH James D. Eason Transplant Institute - University of Tennessee Health Sciences Center - Shorb Tower - Memphis - TN , USA , Nagaraju, Deepa H. UF Health Family Medicine and Pediatrics - Bayberry Road Jacksonville - FL , USA , Katz, Seymour Department of Gastroenterology - NYU Langone Medical Center - Great Neck - NY , USA , Bruckner, Howard Bruckner Oncology - Eastchester Road - Bronx - NY , USA , Itzkowitz, Steven H. Division of Gastroenterology - Icahn School of Medicine at Mount Sinai - New York - NY , USA , Schwartz, Myron he Recanati/Miller Transplantation Institute - Icahn School of Medicine at Mount Sinai - New York - NY , USA
Abstract :
Small bowel adenocarcinoma is a rare but well-known complication of Crohn’s disease. The diagnosis of small boweladenocarcinoma remains difficult since its presentation is highly variable and mimics active or obstructive Crohn’s disease. Thediagnosis is often delayed and typically detected only at surgery in an advanced stage with a poor prognosis. We report a case ofmetastatic ileal adenocarcinoma in a patient with Crohn’s disease with prolonged survival. Our case describes serial promisingtreatment options of these advanced malignancies and raises a possible role for checkpoint immunotherapy
Keywords :
Ileal Adenocarcinoma , Liver Metastasis , Patient , Crohn’s Disease , 9-Year Survival , Small bowel adenocarcinoma (SBA)
